PGNY vs CLOV
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 23, 2026
PGNY
CLOV
Investment Advisor Scores
CLOV
AI Analyst Insights
Detailed Metrics Comparison
| Metric | PGNY | CLOV | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 13.1926 | 81.9672 | PGNY |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 5.3% | 55.6% | CLOV |
| Earnings Growth | 78.9% | 0.0% | PGNY |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 64.4/100 | 34.3/100 | PGNY |
| Profit Margin | 6.0% | -0.7% | PGNY |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | SELL | PGNY |
Relative Price Performance (Last 90 Days)
Current Technical Phase
PGNY
NeutralMixed signals - no dominant trend phase, RSI 34
CLOV
NeutralMixed signals - no dominant trend phase, RSI 43
Fundamentals Snapshot
| Metric | PGNY | CLOV |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 11.3 | 27.7 |
| Trailing P/E | 27.9 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.6% |
| Gross Margin | 0.2% | 0.2% |
| Operating Margin | 0.1% | 0.0% |
| EPS | 0.92 | -0.05 |
| Dividend Yield | — | — |